Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Authors
Publication date
1 January 2022
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Institutional Repository Universiteit Antwerpen

    redirect
    oaic:irua:190052
    Last time updated on 26/09/2022